SAMHD1 deficient human monocytes autonomously trigger type I interferon

Mol Immunol. 2018 Sep:101:450-460. doi: 10.1016/j.molimm.2018.08.005. Epub 2018 Aug 9.

Abstract

Germline mutations in the human SAMHD1 gene cause the development of Aicardi-Goutières Syndrome (AGS), with a dominant feature being increased systemic type I interferon(IFN) production. Here we tested the state of type I IFN induction and response to, in SAMHD1 knockout (KO) human monocytic cells. SAMHD1 KO cells exhibited spontaneous transcription and translation of IFN-β and subsequent interferon-stimulated genes (ISGs) as compared to parental wild-type cells. This elevation of IFN-β and ISGs was abrogated via inhibition of the TBK1-IRF3 pathway in the SAMHD1 KO cells. In agreement, we found that SAMHD1 KO cells present high levels of phosphorylated TBK1 when compared to control cells. Moreover, addition of blocking antibody against type I IFN also reversed elevation of ISGs. These experiments suggested that SAMHD1 KO cells are persistently auto-stimulating the TBK1-IRF3 pathway, leading to an enhanced production of type I IFN and subsequent self-induction of ISGs.

Keywords: AGS; IFN; ISGs; SAMHD1; TBK1-IRF3.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Gene Expression Regulation / drug effects
  • Humans
  • Interferon Type I / metabolism*
  • Monocytes / drug effects
  • Monocytes / metabolism*
  • Protein Biosynthesis / drug effects
  • Pyrimidines / pharmacology
  • SAM Domain and HD Domain-Containing Protein 1 / deficiency*
  • SAM Domain and HD Domain-Containing Protein 1 / metabolism
  • Small Molecule Libraries / pharmacology
  • THP-1 Cells
  • Thiophenes / pharmacology
  • Transcription, Genetic / drug effects

Substances

  • BX795
  • Interferon Type I
  • Pyrimidines
  • Small Molecule Libraries
  • Thiophenes
  • SAM Domain and HD Domain-Containing Protein 1
  • SAMHD1 protein, human